☆ 4.8 Letter

Reply to: 'Management of portal hypertension in patients treated with atezolizumab and bevacizumab for hepatocellular carcinoma'

JOURNAL OF HEPATOLOGY (2022)

Journal

JOURNAL OF HEPATOLOGY

Volume 77, Issue 2, Pages -

Publisher

ELSEVIER

DOI: 10.1016/j.jhep.2022.04.029

Keywords

-

Categories

Gastroenterology & Hepatology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.